Anti‐Müllerian Hormone and Metabolic–Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population‐Based Study
Fahimeh Ramezani Tehrani, Maryam Mousavi, Marzieh Saei Ghare Naz, Maryam Farahmand, Masoumeh Jorjani, Fatemeh Mahboobifard · 2026
Read Anti‐Müllerian Hormone and Metabolic–Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population‐Based Study by Fahimeh Ramezani Tehrani, Maryam Mousavi, Marzieh Saei Ghare Naz, Maryam Farahmand, Masoumeh Jorjani, Fatemeh Mahboobifard (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13425589.txt.
Description
Ramezani Tehrani and co-authors study what a hormone called AMH can reveal about metabolic risk in women with and without polycystic ovary syndrome. AMH reflects the ovary's remaining egg supply and is higher in this syndrome. Whether its link to diabetes and metabolic syndrome changes with age and diagnosis was unclear.
The population study covered 883 women sorted into syndrome, suspicious, and healthy groups. Age explained far less of the hormone's variation in women with the syndrome. Among healthy women over thirty-five, higher AMH meant lower diabetes odds, while in younger women with the syndrome it marked higher metabolic syndrome risk. The authors propose AMH as a life-course risk marker.
Catalog record
| CREATOR | Fahimeh Ramezani Tehrani, Maryam Mousavi, Marzieh Saei Ghare Naz, Maryam Farahmand, Masoumeh Jorjani, Fatemeh Mahboobifard |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |